RecruitingMild to Moderate Asthma
A Study of CDX-622 in Participants With Mild to Moderate Asthma
Eligible age
18+ yrs
Accepts
All genders
Locations
4 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This is a study to determine the safety, pharmacodynamics (PD), and pharmacokinetics (PK) of CDX-622 in adults with mild to moderate asthma.
Sponsor: Celldex Therapeutics
Where it's recruiting
Source: ClinicalTrials.gov · NCT07330778 · last updated 2026-06-04